People: E I du Pont de Nemours and Co (DD.N)

DD.N on New York Stock Exchange

64.93USD
25 Jul 2014
Price Change (% chg)

$-0.27 (-0.41%)
Prev Close
$65.20
Open
$65.28
Day's High
$65.50
Day's Low
$64.85
Volume
1,202,520
Avg. Vol
912,529
52-wk High
$69.75
52-wk Low
$56.09

Search Stocks

DeSalva, AnnaMaria 

Brief Biography

Ms. AnnaMaria DeSalva is the Vice President - Corporate Communications of E. I. du Pont de Nemours and Co. In Possessing a diverse technology-based background, DeSalva has more than 20 years of experience in science-related communications and branding, including a variety of progressive leadership positions with Pfizer, Hill & Knowlton, GCI Group and Bristol-Myers Squibb. Most recently, DeSalva has served as vice president, Corporate Affairs - Biopharma Innovation & Outcomes, at Pfizer where she has been responsible for leading science, medicine, portfolio and strategy corporate affairs. DeSalva is a board director for the National Campaign to End Obesity as well as for INMED Partnerships for Children and she has served as a risk communications adviser to the U.S. Food and Drug Administration.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ellen Kullman

14,152,600

Nicholas Fanandakis

3,921,930

James Borel

3,741,830

Thomas Connelly

3,633,140

Mark Vergnano

3,578,800

Thomas Sager

--
As Of 30 Dec 2013
Search Stocks